EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessment of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in Children with Cardiovascular Diseases

Marta Pasławska-Zyskowska iD, Piotr Majewski iD, Anetta Sulewska iD, Paweł Muszyński iD, Miłosz Nesterowicz iD, Filip Bossowski iD, Joanna Gościk iD, Beata Sawicka, Justyna Dunaj-Małyszko, Anna Moniuszko-Malinowska, Jacek Nikliński, Artur Tadeusz Bossowski iD

Cells · 10.04.2026 · 15 (8) · 674

DOI: 10.3390/cells15080674 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 10.04.2026. Verfasst von Marta Pasławska-Zyskowska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Endocrinology and Diabetes with Cardiology Division, Medical University of Bialystok, Jerzego Waszyngtona 17, 15-274 Bialys…. Hauptthemen laut MEDLINE: MicroRNAs, Cardiovascular Diseases. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Białystok, Medical University of Bialystok.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular diseases remain important causes of morbidity and potential premature mortality in children. Although clinical imaging and electrophysiologic testing have advanced, early, minimally invasive biomarkers that can both detect myocardial injury and help differentiate among overlapping pediatric phenotypes are still limited. Circulating microRNAs (miRNAs; miRs) are becoming attractive biomarker candidates because many are abundant in the heart, actively released into the circulation, and remarkably stable in plasma. The study aimed to assess the expression of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in children with cardiovascular disease.

Methods

Children aged 10–18 years with cardiac arrhythmias, myocarditis, or cardio-myopathies were recruited. The control group consisted of healthy age- and sex-matched children. For each participant, peripheral venous blood was collected for plasma isolation and miRNA profiling. The expression of miR-1-3p, miR-let-7b-5p, miR-21-5p, miR-26b-5p, and UniSp6 molecules was analyzed using the comparative cycle threshold delta Ct (ΔCt) method. A p-value ≤ 0.05 was considered statistically significant. Results: miR-26b-5p was significantly downregulated in patients with cardiac disease compared with healthy controls. miR-21-5p and miR-26b-5p were downregulated in patients with ventricular arrhythmia. Moreover, miR-26b-5p was downregulated in arrhythmia in general. We found no significant difference in the expression of miR-1-3p, miR-let-7b-5p, miR-21b-5p, and miR-26b-5p between patients with and without myocarditis, as well as with and without hypertrophic cardiomyopathy. Conclusions: miR-26b-5p may distinguish young patients with cardiovascular disease and those with arrhythmias from healthy individuals. miR-21-5p and miR-26b-5p may also be seen as potential biomarkers of ventricular arrhythmia. Further studies involving a larger sample size are required to obtain sufficient data and validate these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCardiovascular DiseasesHumansChildFemaleMaleAdolescentBiomarkersCase-Control Studies

Stichwörter der Autor:innen

arrhythmiabiomarkerscardiomyopathycardiovascular diseasechildrenmiR-21-5pmiR-26b-5pmicroRNAmyocarditis

Substanzen

MicroRNAsMIRN26 microRNA, humanMIRN21 microRNA, humanmirnlet7 microRNA, humanBiomarkersMIRN1 microRNA, human

Autor:innen und Institutionen

  • Department of Pediatrics, Endocrinology and Diabetes with Cardiology Division, Medical University of Bialystok, Jerzego Waszyngtona 17, 15-274 Bialystok, Poland.
  • Department of Microbiological Diagnostics and Infectious Immunology, Medical University of Bialystok, Jerzego Waszyngtona 15A, 15-269 Bialystok, Poland.
  • Department of Clinical Molecular Biology, Medical University of Bialystok, Jerzego Waszyngtona 13, 15-269 Bialystok, Poland.
  • Department of Cardiology, Lipidology and Internal Diseases, Medical University of Bialystok, Żurawia 14, 15-540 Bialystok, Poland.
  • Faculty of Computer Science, Bialystok University of Technology, Wiejska 45A, 15-351 Bialystok, Poland.
  • Department of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Żurawia 14/E, 15-540 Bialystok, Poland.

ORCID-Profile: Marta Pasławska-Zyskowska, Piotr Majewski, Anetta Sulewska, Paweł Muszyński, Miłosz Nesterowicz, Filip Bossowski, Joanna Gościk, Artur Tadeusz Bossowski

Förderung

  • Medical University of Białystok
  • Medical University of Bialystok

Zitieren

APA

Pasławska-Zyskowska, M., Majewski, P., Sulewska, A., Muszyński, P., Nesterowicz, M., Bossowski, F., Gościk, J., Sawicka, B., Dunaj-Małyszko, J., Moniuszko-Malinowska, A., Nikliński, J., & Bossowski, A. T. (2026). Assessment of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in Children with Cardiovascular Diseases. Cells, 15(8), 674. https://doi.org/10.3390/cells15080674

Vancouver

Pasławska-Zyskowska M, Majewski P, Sulewska A, Muszyński P, Nesterowicz M, Bossowski F, et al. Assessment of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in Children with Cardiovascular Diseases. Cells. 2026;15(8):674. doi:10.3390/cells15080674

BibTeX
@article{PasawskaZyskowska2026,
  author = {Pasławska-Zyskowska, Marta and Majewski, Piotr and Sulewska, Anetta and Muszyński, Paweł and Nesterowicz, Miłosz and Bossowski, Filip and Gościk, Joanna and Sawicka, Beata and Dunaj-Małyszko, Justyna and Moniuszko-Malinowska, Anna and Nikliński, Jacek and Bossowski, Artur Tadeusz},
  title = {Assessment of miR-1-3p, miR-let-7b-5p, miR-21-5p, and miR-26b-5p in Children with Cardiovascular Diseases},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {674},
  doi = {10.3390/cells15080674}
}
Kostenlos starten →